XVIVO Scientific Animation
  • Services
    • All Services
    • Medical Animation
    • Illustration
    • Interactive
  • About
    • About Us
    • Process
    • Our Team
  • Portfolio
  • Blog
  • Contact

Example Type: Rare Disease Animation

  • A FOCUS ON ALK-POSITIVE NON-SMALL CELL LUNG CANCER

    February 4, 2021

    By admin

    In partnership with Wedgewood Communications, XVIVO developed two videos for Takeda Oncology to discuss lung cancer mechanism of disease and treatments.
    Read More
  • THORACIC OUTLET SYNDROME

    February 4, 2021

    By admin

    Dr. Parth Shah, the Director of Vascular and Endovascular Surgery at the Thoracic Outlet Center …
    Read More
  • VOXELOTOR AN INVESTIGATIONAL DRUG FOR SICKLE CELL DISEASE

    February 4, 2021

    By admin

    In collaboration with Global Blood Therapeutics, our folks here at XVIVO created this medical animation to illustrate the mechanism of action of a potential drug candidate for the treatment of sickle cell disease (SCD).
    Read More
  • IDIOPATHIC PULMONARY FIBROSIS AND THE EFFECTS OF TREATMENT

    February 4, 2021

    By admin

    The animation, developed in partnership with Wedgewood Communications, shows the mechanism of disease for IPF and the mechanism of action for the recently-approved agent OFEV (nintedanib) from Boehringer Ingelheim.
    Read More
  • PALOVAROTENE MOA

    February 4, 2021

    By admin

    Fibrodysplasia ossificans progressiva, or FOP, is an extremely rare and debilitating disorder, in which bone …
    Read More

Can't Get Enough of XVIVO?

We’ve got you covered! Check out our latest wallpapers for stunning visuals!

Wallpapers

Contact Us

Have a question, need a quote, or don’t see what you are looking for? Just fill out this brief project inquiry to get in touch with us.

  • This field is for validation purposes and should be left unchanged.
XVIVO Scientific Animation
  • Services
  • Portfolio
  • About
  • Blog
  • Contact
  • Wallpapers
  • 860.721.9848
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn
  • Terms & Conditions
Copyright 2023